HomeCompareAPLT vs PM

APLT vs PM: Dividend Comparison 2026

APLT yields 1941.75% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 APLT wins by $7549549081.29M in total portfolio value
10 years
APLT
APLT
● Live price
1941.75%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7549549081.34M
Annual income
$6,855,073,294,458,854.00
Full APLT calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — APLT vs PM

📍 APLT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPLTPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APLT + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APLT pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APLT
Annual income on $10K today (after 15% tax)
$165,048.54/yr
After 10yr DRIP, annual income (after tax)
$5,826,812,300,290,026.00/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, APLT beats the other by $5,826,812,300,287,908.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APLT + PM for your $10,000?

APLT: 50%PM: 50%
100% PM50/50100% APLT
Portfolio after 10yr
$3774774540.69M
Annual income
$3,427,536,647,230,673.00/yr
Blended yield
90.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

APLT
Analyst Ratings
5
Buy
5
Hold
1
Sell
Consensus: Buy
Price Target
$0.25
+142.7% upside vs current
Range: $0.25 — $0.25
Altman Z
-35.3
Piotroski
1/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APLT buys
0
PM buys
0
No recent congressional trades found for APLT or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPLTPM
Forward yield1941.75%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$7549549081.34M$49.6K
Annual income after 10y$6,855,073,294,458,854.00$2,492.02
Total dividends collected$7500143229.39M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy
Analyst price target$0.25$194.30

Year-by-year: APLT vs PM ($10,000, DRIP)

YearAPLT PortfolioAPLT Income/yrPM PortfolioPM Income/yrGap
1← crossover$204,875$194,174.76$11,648$408.29+$193.2KAPLT
2$3,937,114$3,717,897.78$13,589$495.90+$3.92MAPLT
3$70,986,064$66,773,352.36$15,877$603.21+$70.97MAPLT
4$1,201,115,737$1,125,160,648.71$18,580$734.88+$1201.10MAPLT
5$19,077,920,928$17,792,727,089.23$21,781$896.75+$19077.90MAPLT
6$284,535,588,112$264,122,212,719.20$25,578$1,096.12+$284535.56MAPLT
7$3,985,969,128,556$3,681,516,049,275.53$30,092$1,342.17+$3985969.10MAPLT
8$52,464,234,462,079$48,199,247,494,524.41$35,470$1,646.46+$52464234.43MAPLT
9$649,042,791,475,683$592,906,060,601,258.60$41,892$2,023.58+$649042791.43MAPLT
10$7,549,549,081,337,835$6,855,073,294,458,854.00$49,578$2,492.02+$7549549081.29MAPLT

APLT vs PM: Complete Analysis 2026

APLTStock

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Full APLT Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this APLT vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APLT vs SCHDAPLT vs JEPIAPLT vs OAPLT vs KOAPLT vs MAINAPLT vs MOAPLT vs BTIAPLT vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.